Global Pharmaceuticals & Biotech Leverage Leaders

Biogen

Market Cap: US$29.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

ACADIA Pharmaceuticals

Market Cap: US$4.3b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Trevi Therapeutics

Market Cap: US$2.5b

A clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

SCHOTT Pharma KGaA

Market Cap: €3.1b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Dianthus Therapeutics

Market Cap: US$5.7b

A clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases.

Nurix Therapeutics

Market Cap: US$2.4b

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Corcept Therapeutics

Market Cap: US$10.2b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Exelixis

Market Cap: US$13.9b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Vaxcyte

Market Cap: US$7.9b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Stevanato Group

Market Cap: US$5.4b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

AtaiBeckley

Market Cap: US$2.7b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥39.3b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Tasly Pharmaceutical Group

Market Cap: CN¥23.8b

Engages in the research, development, production, and sale of pharmaceuticals in China.

Asymchem Laboratories (Tianjin)

Market Cap: CN¥56.9b

Asymchem Laboratories (Tianjin) Co., Ltd.

Imeik Technology DevelopmentLtd

Market Cap: CN¥31.5b

Engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China.

Otsuka Holdings

Market Cap: JP¥5.9t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥353.7b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Aurobindo Pharma

Market Cap: ₹891.5b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

Sai Life Sciences

Market Cap: ₹273.0b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Sun Pharmaceutical Industries

Market Cap: ₹4.7t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Aether Industries

Market Cap: ₹196.4b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Alkem Laboratories

Market Cap: ₹671.0b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Kiniksa Pharmaceuticals International

Market Cap: US$4.8b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

Merck KGaA

Market Cap: €61.6b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

United Therapeutics

Market Cap: US$22.4b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Camurus

Market Cap: SEK 36.7b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bachem Holding

Market Cap: CHF 5.5b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

Orion Oyj

Market Cap: €11.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Structure Therapeutics

Market Cap: US$3.5b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

Regeneron Pharmaceuticals

Market Cap: US$66.7b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Sanofi

Market Cap: €93.5b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Sionna Therapeutics

Market Cap: US$2.1b

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

Jiangsu Nhwa Pharmaceutical

Market Cap: CN¥21.8b

Engages in research, development, production, and sale of central nervous system products in China.

Peptron

Market Cap: ₩3.0t

Engages in the development of peptide-based medicines.

Hanmi Pharm

Market Cap: ₩5.0t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Harbin Pharmaceutical Group

Market Cap: CN¥14.2b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.